TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
LAB

Standard Biotools Inc

Healthcare · Medical Devices · —

0.73$ +2.9% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Standard Biotools Inc (LAB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 47.0% of the shares are freely tradable; institutional investors hold 76.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 76.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 47.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 1.3%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 393Mio.

Largest Shareholders

Institutions

Institutions LAB
Name Stake (%) Shares Change (%) Date
Casdin Capital, LLC 22.62 88,783,856 +0.0 06/30/2026
Viking Global Investors LP 14.94 58,651,170 +0.0 03/31/2026
Mak Capital One LLC 6.67 26,172,626 +35.7 03/31/2026
BlackRock Inc 6.31 24,756,084 -3.0 03/31/2026
Long Focus Capital Management, LLC 5.99 23,500,000 +46.7 06/30/2026
Vanguard Capital Management, LLC 3.26 12,816,070 +0.0 03/31/2026
Geode Capital Management, LLC 1.86 7,289,336 -1.8 03/31/2026
State Street Corp 1.67 6,556,509 +1.1 03/31/2026
Hollow Brook Wealth Management, LLC 1.44 5,653,381 +1.8 03/31/2026

Funds

Funds LAB
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.21 8,677,842 +2.9 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings LAB
Person Role Shares Value As of Type
Egholm Michael President & CEO 6,137,704 4,480,524 $ Aug 20, 2026 direct
Kim Hanjoon Alex Chief Financial Officer 2,534,859 1,850,447 $ Aug 20, 2026 direct
Mackay Sean SVP & Chief Business Officer 1,480,823 1,081,001 $ Aug 20, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 20, 2026 Mackay Sean SVP & Chief Business Officer Other 25,729 0.672 17,290
Aug 20, 2026 Kim Hanjoon Alex Chief Financial Officer Other 28,195 0.672 18,947
Aug 20, 2026 Egholm Michael President & CEO Other 97,627 0.672 65,605
Aug 3, 2026 Egholm Michael President & CEO Other 362,625 0.868 314,759
Jul 23, 2026 Kim Hanjoon Alex Chief Financial Officer Other 202,476 0.895 181,216

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?